Table of Contents

Abstract Antipsychotics for Youth at Risk for Psychosis Not Supported as First Option Relative Age in Class Affects ADHD Stimulant Treatment Survey Analysis Does Not Point to Overmedication Hyperprolactinemia Found in Risperidone‐Treated Youth Free the Future: Investment in MH Services Crucial Post‐Newtown Pediatric Social Anxiety Disorder: Predictors of Response to Pharmacological Treatment Ziprasidone vs. Olanzapine for 1st‐Episode Schizophrenia Utilization and Cost of Antipsychotics in Stimulant‐Treated Youth Acute Myocardial Infarction in Teen Taking Adderall with Alcohol Managing Side Effects of ADHD Medications New Requirements for Zolpidem Products
Source: The Brown University Child and Adolescent Psychopharmacology Update - Category: Psychiatry Source Type: research